Jan 31, 2019 8:00 am EST Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™
Jan 8, 2019 1:00 pm EST Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments
Dec 6, 2018 12:30 pm EST Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day
Nov 13, 2018 8:45 am EST Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference
Nov 9, 2018 4:20 pm EST Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights
Nov 5, 2018 7:00 am EST Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
Oct 18, 2018 8:03 am EDT Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer
